After Extensions, University Responds In Antiviral, Anticancer Patent Row

Mealey's (January 28, 2020, 1:18 PM EST) -- ALEXANDRIA, Va. — In a Jan. 24 preliminary response, the Regents of the University of Minnesota (Minnesota) argues that the Patent Trial and Appeal Board should reject a request for inter...

To view the full article, register now.